Holen Sie sich die Stockscreener-App
4.72
0.63%
-0.03
Handel nachbörslich:
4.60
-0.12
-2.54%
Schlusskurs vom Vortag:
$4.75
Offen:
$4.77
24-Stunden-Volumen:
224.22K
Relative Volume:
0.74
Marktkapitalisierung:
$302.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.08M
KGV:
-6.4658
EPS:
-0.73
Netto-Cashflow:
$-33.68M
1W Leistung:
+9.01%
1M Leistung:
-5.60%
6M Leistung:
+265.89%
1J Leistung:
+82.95%
1-Tages-Spanne:
$4.56
$4.7779
1-Wochen-Bereich:
$4.375
$4.8468
52-Wochen-Spanne:
$0.726
$6.55
Galectin Therapeutics Inc Stock (GALT) Company Profile
Firmenname
Galectin Therapeutics Inc
Sektor
Branche
Telefon
678-620-3186
Adresse
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Vergleichen Sie GALT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
4.72 | 304.29M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-13 | Eingeleitet | B. Riley FBR | Buy |
| 2017-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-19 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Herabstufung | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Herabstufung | ROTH Capital | Buy → Sell |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-09-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-08-01 | Herabstufung | Aegis Capital | Buy → Hold |
| 2014-07-30 | Bestätigt | MLV & Co | Buy |
| 2014-07-29 | Bestätigt | MLV & Co | Buy |
| 2014-04-02 | Bestätigt | MLV & Co | Buy |
| 2014-02-10 | Bestätigt | Aegis Capital | Buy |
| 2014-01-09 | Bestätigt | Aegis Capital | Buy |
| 2013-12-03 | Eingeleitet | MLV & Co | Buy |
| 2013-08-19 | Bestätigt | Aegis Capital | Buy |
Alle ansehen
Galectin Therapeutics Inc Aktie (GALT) Neueste Nachrichten
Can machine learning forecast Galectin Therapeutics Inc. recoveryJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
Trend analysis for Galectin Therapeutics Inc. this weekQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com
Galectin Therapeutics Inc Stock Analysis and ForecastMarket Depth Overview & Big Profit Low Trading - earlytimes.in
Galectin Therapeutics' (GALT) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Should Dividend Investors Consider Omnipotent Industries Limited in YEAREconomic Data Impact & Free Dashboard to Track Market Momentum - earlytimes.in
Is Galectin Therapeutics Inc a good long term investmentChart Pattern Recognition & Connect With Bulls, Avoid the Bears - earlytimes.in
Prevents Varices at 18 Months — Galectin Therapeutics to Present NAVIGATE Data at AASLD Nov 10 - Stock Titan
Will Galectin Therapeutics Inc. (PHPN) stock hit Wall Street targetsJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
How sentiment analysis helps forecast Galectin Therapeutics Inc.July 2025 Decliners & Verified Short-Term Plans - newser.com
Market reaction to Galectin Therapeutics Inc.’s recent newsQuarterly Market Review & Fast Gain Stock Trading Tips - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metricsPortfolio Update Summary & Weekly Breakout Opportunity Watchlist - newser.com
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Summary & Daily Price Action Insights - newser.com
Analyzing Galectin Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Galectin Therapeutics Inc. forecastingWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
Chart overlay techniques for tracking Galectin Therapeutics Inc.July 2025 Recap & Precise Swing Trade Alerts - newser.com
What drives Galectin Therapeutics Inc PHPN stock pricePrice Momentum Alerts & High Yield Market Growth - earlytimes.in
What drives Galectin Therapeutics Inc stock priceDouble Top/Bottom Patterns & Free Double Digit Growth Tips - earlytimes.in
Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Galectin Therapeutics Inc-Aktie (GALT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CALLICUTT JACK W | Chief Financial Officer |
Sep 12 '25 |
Sale |
6.44 |
8,706 |
56,054 |
7,614 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Option Exercise |
2.39 |
14,000 |
33,460 |
846,592 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Sale |
6.36 |
14,000 |
89,048 |
832,592 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):